News

Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...
From 2010 to 2020, breast cancer deaths among women ages 20–49 declined significantly across all breast cancer subtypes and ...
The data, presented in a poster titled "AP402, a bispecific antibody targeting p95HER2 and CD137, shows potent antitumor activity," highlight the therapeutic potential of AP402 to address ...
Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today outlined a framework for a ...